FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | ||
|
|||
Member
|
didn't exactly get star billing at the latest Bayer Investor day but two key messages :
i) It survived a rigorous pipeline cull. ii) It is expected to enter P3 in 2008 and the market in 2011. Go Spheramine. Neil. |
||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
Spheramine patient believes | New Member Introductions | |||
spheramine interest | New Member Introductions | |||
Spheramine Phase 2, Patient no. 1, he says .. | Parkinson's Disease | |||
Spheramine Trials (STEPS) | Parkinson's Disease |